Evidence map›Paper›PMID 41682779›Full record

ReviewJournal of clinical medicine2026

Safety and Efficacy of Direct Oral Anticoagulants Versus Standard Therapy for Venous Thromboembolism in Cancer Patients: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.

Alaa Shahbar, Sabah Alshahrani, Abdullah Alhifany, Mohammed Alnuhait, Afnan Noor, Abdulaali Almutairi, Faisal A Alhamdan, Ahmad A Alshamrani, Alqassem Y Hakami

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alaa ShahbarPharmacy Practices Department, College of Pharmacy, Umm Al-Qura University, Taif Road, Alabdiah, Makkah 21955, Saudi Arabia.ORCID 0000-0002-0171-7391
Sabah AlshahraniAsir Health Cluster, Asir Central Hospital, Clinical Pharmacy Department, Abha 62523, Saudi Arabia.
Abdullah AlhifanyPharmacy Practices Department, College of Pharmacy, Umm Al-Qura University, Taif Road, Alabdiah, Makkah 21955, Saudi Arabia.
Mohammed AlnuhaitDepartment of Clinical Pharmacy, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Al-Dawadmi 11961, Saudi Arabia.ORCID 0000-0002-5279-5437
Afnan NoorPharmaceutical Care Services Department, King Faisal Specialist Hospital and Research Center, Jeddah 23433, Saudi Arabia.
Abdulaali AlmutairiDepartment of Pharmacy Practice, College of Pharmacy, Alfaisal University, Riyadh 11533, Saudi Arabia.
Faisal A AlhamdanKing Abdullah International Medical Research Center, Jeddah 22384, Saudi Arabia.
Ahmad A AlshamraniKing Abdullah International Medical Research Center, Jeddah 22384, Saudi Arabia.
Alqassem Y HakamiKing Abdullah International Medical Research Center, Jeddah 22384, Saudi Arabia.ORCID 0000-0003-2477-1339

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancerCRNMBdirect oral anticoagulantslow molecular weight heparinmajor bleedingVTE recurrencewarfarin

Identifiers

PMID41682779
PMCPMC12898735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.